Pramod Deshmukh, MD
Cardiovascular Disease · Sayre, PANPI 1548235484
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $30,340 of the $42,440 with a category attached, or 71.5%. Abbott accounts for 84.5% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2019 at $28,422 and has fallen 90.4% since, to $2,733 in 2025. Among cardiovascular disease clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 146 payments — averaging $290.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$36K
- Medtronic$4K
- Boston Scientific$2K
- Biotronik Inc.$394
- Pfizer$156
- Atricure, Inc.$116
- plus $226 from 6 others
Across 103 payments — averaging $2011.56 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$207K
What the payments were for
- Consulting fees$30,34071%
- Travel & lodging$9,15922%
- Food & beverage$2,8827%
- Education$590%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 48 | $35,845 |
| Medtronic(2 entities) | 23 | $3,513 |
| Boston Scientific | 27 | $2,190 |
| Biotronik Inc. | 23 | $394 |
| Pfizer | 10 | $156 |
| Atricure, Inc. | 1 | $116 |
| Johnson & Johnson | 6 | $90 |
| Amgen | 3 | $53 |
| E.r. Squibb & Sons, L.L.C. | 2 | $30 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $28 |
| Abiomed | 1 | $13 |
| Bardy Diagnostics, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Assurity Pacemaker$14,290
- Agilis NxT EP Introducer$6,345
- Nanostim Leadleas Pacemaker$5,600
- IsoFlex Pacing Lead$2,800
- Allure Quadra RF CRT Pacemaker$2,550
- AVEIR$1,655
- Micra$1,335
- Cardiovascular- Research only$1,192
- TENDRIL$425
- Farapulse$345
- EVERA MRI XT DR SURESCAN$209
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$116
How this compares
$42,440 in reported general payments places this provider in the 90th percentile of 1,250 cardiovascular disease providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amiodarone Hcl | 20 | $493 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Sayre
- Hemal GadaWormleysburg$1.8M
- Benjamin KalsmithPgh$1.7M
- Peter KoweyWynnewood$1.5M
- Paul ForfiaPhiladelphia$1.2M
- Quang BuiPhiladelphia$933K
- Rhian DaviesYork$853K
- Sarang MangalmurtiBryn Mawr$728K
- Sabahat BokhariAllentown$578K
- George GabrielPittsburgh$563K
- Rajesh DaveCamp Hill$442K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.